top of page
PARK CITY 2025: RETINA – GENE THERAPY AND NOVEL MECHANISMS OF ACTION SHOWCASE
Moderators: Allen C. Ho, MD, Retina Program Director and Namrata Saroj, OD, Chief Business Officer, Ocular Therapeutix, Inc.
Room: Strawberry Ballroom
Start | Company | Presenter |
|---|---|---|
1:30 PM | Introduction | Allen C. Ho, MD, Retina Program Director |
1:31 PM | Neurotech Pharmaceuticals, Inc. | Rich Small, CEO |
1:36 PM | Discussion | |
1:38 PM | LumiThera, Inc. | Clark E. Tedford, PhD, President & CEO |
1:43 PM | Discussion | |
1:45 PM | Ocutheia, Inc. | Thomas Wubben, MD, PhD, Co-Founder & CEO |
1:50 PM | Discussion | |
1:52 PM | Kiora Pharmaceuticals, Inc. | Brian M Strem, PhD, CEO |
1:57 PM | Discussion | |
1:59 PM | Nanoscope Therapeutics | Jared Stephens, PhD, Vice President, Strategy and Business Development |
2:04 PM | Discussion | |
2:06 PM | Ocugen Inc | Huma Qamar MD, MPH, CMI, Chief Medical Officer |
2:11 PM | Discussion | |
2:13 PM | C5 Therapeutics | Carl Erickson, MBA, CEO |
2:18 PM | Discussion | |
2:20 PM | 4DMT | Dhaval Desai, PharmD, Chief Development Officer |
2:25 PM | Discussion | |
2:27 PM | Adverum Biotechnologies, Inc. | Star Seyedkazemi, PharmD, Chief Development Officer |
2:32 PM | Discussion | |
2:34 PM | Regenxbio | Sumie Takahara, Executive Director Global Product and Marketing Planning |
2:39 PM | Discussion | |
2:41 PM | Dragonfleye Therapeutics Corp. | Rajeev H. Muni MD, MSc, FRCSC, CEO |
2:46 PM | Discussion | |
2:48 PM | Pykus Therapeutics, Inc. | James (Tony) Stefater, MD, PhD, President & Co-Founder |
2:53 PM | Discussion | |
2:55 PM | Ocudyne, Inc. | Jeff Franco, MBA, CEO |
3:00 PM | Discussion | |
3:02 PM | Conclusion | Allen C. Ho, MD, Retina Program Director |
Anchor 1
bottom of page